StudyFinder

Observational Study of Pediatric Rheumatic Diseases: The CARRA Registry

RECRUITING

Continuation of the CARRA Registry as described in the protocol will support data collection on patients with pediatric-onset rheumatic diseases. The CARRA Registry will form the basis for future CARRA studies. In particular, this observational registry will be used to answer pressing questions about therapeutics used to treat pediatric rheumatic diseases, including safety questions.

I'm interested

ALL
Up to 21 years old
This study is NOT accepting healthy volunteers

Inclusion Criteria:

  1. Onset of rheumatic disease prior to age 16 years for JIA and onset prior to age 19 years for all other rheumatic diseases (see appendix A).
  2. Subject (and/or parent/legal guardian when required) is able to provide written informed consent and willing to comply with study procedures.
  3. Subject and/or parent/legal guardian is willing to be contacted in the future by study staff.

Exclusion Criteria:

1. Greater than 21 years of age at the time of enrollment.

Rheumatic Joint Disease

Systemic Arthritis, Oligoarthritis, Polyarthritis (Rheumatoid Factor Negative), Polyarthritis (Rheumatoid Factor Positive), Psoriatic Arthritis, Enthesitis Related Arthritis (ERA), Undifferianted Arthritis, CARRA Consensus Treatment Plans

Megan Quinlan-Waters - megan.quinlan-waters@cchmc.org
NCT02418442
See this study on ClinicalTrials.gov

Back